Pulmonary Disease, Chronic Obstructive
"Pulmonary Disease, Chronic Obstructive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Concept/Terms
Airflow Obstruction, Chronic- Airflow Obstruction, Chronic
- Airflow Obstructions, Chronic
- Chronic Airflow Obstructions
- Chronic Airflow Obstruction
Below are MeSH descriptors whose meaning is more general than "Pulmonary Disease, Chronic Obstructive".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Disease, Chronic Obstructive".
This graph shows the total number of publications written about "Pulmonary Disease, Chronic Obstructive" by people in Harvard Catalyst Profiles by year, and whether "Pulmonary Disease, Chronic Obstructive" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2001 | 6 | 0 | 6 |
2002 | 13 | 5 | 18 |
2003 | 14 | 7 | 21 |
2004 | 18 | 5 | 23 |
2005 | 17 | 10 | 27 |
2006 | 26 | 9 | 35 |
2007 | 29 | 8 | 37 |
2008 | 31 | 8 | 39 |
2009 | 39 | 17 | 56 |
2010 | 49 | 9 | 58 |
2011 | 60 | 14 | 74 |
2012 | 54 | 11 | 65 |
2013 | 55 | 12 | 67 |
2014 | 79 | 15 | 94 |
2015 | 69 | 19 | 88 |
2016 | 67 | 16 | 83 |
2017 | 67 | 11 | 78 |
2018 | 94 | 9 | 103 |
2019 | 75 | 20 | 95 |
2020 | 73 | 15 | 88 |
2021 | 101 | 10 | 111 |
2022 | 78 | 2 | 80 |
2023 | 77 | 0 | 77 |
2024 | 9 | 0 | 9 |
Below are the most recent publications written about "Pulmonary Disease, Chronic Obstructive" by people in Profiles.
-
Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis. Ann Am Thorac Soc. 2024 Mar; 21(3):421-427.
-
Sustained Clinical Benefits of Spiration Valve System in Patients with Severe Emphysema: 24-Month Follow-Up of EMPROVE. Ann Am Thorac Soc. 2024 Feb; 21(2):251-260.
-
Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema. Am J Respir Crit Care Med. 2024 Feb 01; 209(3):273-287.
-
Real-world users of triple therapy for asthma in the US. Am J Manag Care. 2024 Feb; 30(2):74-81.
-
Protocol for the air purification for eosinophilic COPD study (APECS): a randomised controlled trial of home air filtration by HEPA. BMJ Open. 2024 01 18; 14(1):e074655.
-
Genome-wide association study of preserved ratio impaired spirometry (PRISm). Eur Respir J. 2024 01; 63(1).
-
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Ann Intern Med. 2024 01; 177(1):eL230429.
-
Spatial Transcriptomics Resolve an Emphysema-Specific Lymphoid Follicle B Cell Signature in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2024 Jan 01; 209(1):48-58.
-
Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. Am J Respir Crit Care Med. 2024 Jan 01; 209(1):59-69.
-
Prediction and stratification of longitudinal risk for chronic obstructive pulmonary disease across smoking behaviors. Nat Commun. 2023 Dec 14; 14(1):8297.